NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare to ace the NAPLEX. Utilize flashcards and multiple choice questions with hints and explanations. Equip yourself thoroughly for the exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Adding on to daily XOI therapy for gout, if UA remains > 6, includes all except which of the following?

  1. Lesinurad

  2. Probenecid

  3. Acetaminophen

  4. IV Pegloticase

The correct answer is: Acetaminophen

In the context of gout management, when the uric acid (UA) levels remain above 6 despite daily xanthine oxidase inhibitor (XOI) therapy, additional pharmacological interventions may be needed to achieve the target UA levels and prevent gout flares. Option A, Lesinurad, is a selective uric acid reabsorption inhibitor that can be considered to help lower UA levels in patients with gout who have not achieved the target levels with XOI therapy alone. Option B, Probenecid, is a uricosuric agent that works by increasing the excretion of uric acid by the kidneys, thereby lowering UA levels. It is another option that can be added on to XOI therapy in patients with gout who have not achieved the desired UA levels. Option D, IV Pegloticase, is a recombinant uricase enzyme indicated for the treatment of chronic gout in adult patients who have not responded adequately to conventional therapy. Pegloticase works by converting uric acid into allantoin, a more soluble compound that is easily excreted by the kidneys, thus lowering UA levels. Option C, Acetaminophen, is not typically used to lower uric acid levels in gout patients. Acetaminophen is commonly used for pain relief and fever reduction but does not directly impact uric acid levels. Therefore, it would not be a suitable option to add on to daily XOI therapy for gout in the scenario described in the question.